Lieber Institute, Inc.

United States of America

 
Total IP 38
Total IP Rank # 37,140
IP Activity Score 2.5/5.0    39
IP Activity Rank # 19,250
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

15 4
3 0
16 0
0
 
Last Patent 2025 - Peripherally and luminally-restr...
First Patent 2015 - Peripherally restricted gaba pos...
Last Trademark 2019 - LIEBER INSTITUTE FOR BRAIN DEVEL...
First Trademark 2013 - LIEBER INSTITUTE FOR BRAIN DEVEL...

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Use of sobetirome and prodrugs and derivatives thereof for treating pitt-hopkins syndrome. The u...
2023 Invention Peripherally restricted gaba positive allosteric modulators for the treatment of irritable bowel ...
Invention Use of a gaba-a pam for reduction of tactile hypersensitivity. The present disclosure provides me...
Invention Non-acid inhibitors of inositol hexakisphosphate kinase (ip6k) and methods of use thereof. Compou...
Invention Compositions and method for the treatment of x-linked dystonia parkinsonism. Disclosed herein are...
2022 Invention Peripherally and luminally-restricted inhibitors of the serotonin transporter as treatments for d...
Invention Methyl-substituted pyridine and pyridazine compounds, derivatives thereof, and methods of their u...
Invention Substituted benzopyrazolo[1,5-a][1,4]diazepines as gaba positive allosteric modulators. This disc...
Invention Peripherally restricted gaba positive allosteric modulators. This disclosure features chemical en...
2021 Invention Compounds for inhibiting inositol hexakisphosphate kinase (ip6k) and methods of use thereof. Comp...
Invention Compounds which inhibit rna polymerase. This disclosure features chemical entities (e.g., a comp...
Invention Compounds which inhibit rna polymerase and their use. This disclosure features chemical entities...
Invention Compounds which inhibit rna polymerase. This disclosure features chemical entities (e.g., a compo...
Invention Compounds which inhibit rna polymerase and their use. This disclosure features chemical entities ...
Invention Compounds which inhibit rna polymerase, compositions including such compounds, and their use. RN...
Invention Comt inhibiting methods and compositions. This invention relates to compounds, pharmaceutical co...
2020 Invention Kv11.1-3.1 inhibiting methods and compositions. Compounds of formula (I), formula (II)...
Invention Kv11.1-3.1 inhibiting methods and compositions. Compounds of formula (I), formula (II), or formul...
2019 G/S Scientific and medical research and biomedical research services in the field of neurobiology, ph...
Invention Pyridine carboxamide compounds for inhibiting nav1.8. Pyridine carboxamide compounds for inhibiti...
Invention Pyridazine compounds for inhibiting nav1.8. Pyridazine compounds for inhibiting NaV1.8 and method...
G/S Educational services, namely, providing on-line articles and relevant commentary in the field of ...
2016 Invention Comt inhibiting methods and compositions. Compounds that inhibit COMT enzyme and pharmaceutical c...
Invention Treatment of neurological and neurodevelopmental diseases and disorders associated with aberrant ...
2013 G/S Scientific and medical research and biomedical research services in the fields of neurobiology, p...